(Glycopyrrolate Inhalation Solution)
Composition:
Each 2 ml respule contains:
Glycopyrrolate IP 25 mcg
Description:
Gyflo Respules are a long-acting muscarinic antagonist (LAMA) formulation indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. Glycopyrrolate acts by inhibiting acetylcholine at muscarinic receptors in the airways, leading to bronchodilation and improved airflow.
Indications:
Maintenance treatment of COPD
Chronic bronchitis
Emphysema
Key Benefits:
Provides sustained bronchodilation
Reduces frequency of COPD exacerbations
Improves lung function and daily activity tolerance
Packaged in ready-to-use unit dose respules for convenient nebulization
Non-steroidal and well-tolerated with minimal systemic absorption
Price: